• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/23

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

23 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)

H2 blockers

Cimetidine


Ranitidine


Famotidine


Nizatidine

Table for 2 - take before you dine

H2 mechanism

Reversible block of H2 receptors


Decreases H+ secretion by parietal cells

H2 clinical use

Peptic ulcer


Gastritis


Mild esophageal reflux

H2 toxicity

C - potent CP450 inhibitor + antiandrogenic effects - prolactin release, gynaecomastia, impotence, decreased libido in males


Cross placenta and BBB - confusion, dizziness, headaches


C + R - decrease renal excretion of creatinine

PPIs

Omeprazole


Lansoprazole


Esomeprazole


Pantoprazole


Dexlansoprazole

PPI mechanism

Irreversibly inhibits H/K ATPase in stomach parietal cells

PPI clinical use

Peptic ulcer


Gastritis


Esophageal reflux


Z-E syndrome

PPI toxicity

Increased risk of C diff, pneumonia


Hip fractures


Decreased serum magnesium

Bismuth, sulcralfate

Bind to ulcer base - provides physical protection - allows bicarbonate secretion to reestablish ph gradient in mucous layer


Increases ulcer healing


Travellers diarrhoea

Misoprostol

PGE1 analogue. Increases production and secretion of gastric mucous barrier. Decreases acid production


Prevents NSAID-induced peptic ulcers - NSAIDS block PGE1 production


Maintenance of PDA


Induction of labour - ripens cervix


SE = diarrhoea, CI in women of child bearing

Octreotide

Long acting somatostatin analog


Acute variceal bleeds


Acromegaly


VIPoma


Carcinoid tumours


SE = nausea, cramps, steatorrhea

Antacid use

Alters gastric and urinary ph/delays gastric emptying -> Affects absorption, bioavailability, urinary excretion of other drugs


All can cause hypokalemia

Aluminium hydroxide OU

Constipation


Hypophosphatemia


Proximal muscle weakness


Osteodystrophy


Seizures

Calcium carbonate OU

Hypercalcemia


Rebound acid increase


Can chelate the effectiveness of other drugs - tetracycline

Magnesium hydroxide OU

Diarrhoea


Hyporeflexia


Hypotension


Cardiac arrest

Osmotic laxatives

Magnesium hydroxide


Magnesium citrate


Polyethylene glycol


Lactulose

OL mechanism

Provide osmotic load - draws water out


Lactulose = hepatic encephalopathy - gut flora degrade it into metabolites that promote nitrogen excretion as NH4+ = lactic acid + acetic acid

OL clinical use

Constipation

OL toxicity

Diarrhoea


Dehydration


May be caused by bulimics

Infliximab

Monoclonal Ab to TNF alpha


Crohn disease


Ulcerative colitis


RA


Ankylosing spondylitis


Psoriasis


SE = infection, reactivation of latent TB, fever, hypotension

Sulfasalazine

Antibacterial sulfapyridine + antiInf 5-ASA


Activated by colonic bacteria


UC


Crohn's disease


SE = malaise, nausea, Sulfonamide toxicity, reversible oligospermia

Ondansetron

5-HT3 antagonist


Increases vagal stimulation


Central-acting antiemetic


Controls vomiting postOP and in chemo pts


SE = headache, constipation

Metoclopramide

D2 receptor antagonist


Increases resting tone, contractility, LES tone, motility


No influence on colon transport time


Diabetic and postOP gastroparesis, antiemetic


SE = increases Parkinsonian effects - restlessness, drowsiness, fatigue, depression, nausea, diarrhoea


Interacts with digoxin and diabetic agents


CI in pts with small bowel obstruction or Parkinson's